Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)
Others
Ratios

China Pharma Holdings (CPHI) Other Operating Expenses (2016 - 2025)

China Pharma Holdings (CPHI) has disclosed Other Operating Expenses for 16 consecutive years, with $103343.0 as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Other Operating Expenses fell 22.27% year-over-year to $103343.0, compared with a TTM value of $467982.0 through Sep 2025, down 25.36%, and an annual FY2024 reading of $534526.0, down 30.09% over the prior year.
  • Other Operating Expenses was $103343.0 for Q3 2025 at China Pharma Holdings, roughly flat from $103324.0 in the prior quarter.
  • Across five years, Other Operating Expenses topped out at $440734.0 in Q2 2021 and bottomed at $85788.0 in Q1 2025.
  • Average Other Operating Expenses over 5 years is $200383.1, with a median of $174040.0 recorded in 2022.
  • The sharpest move saw Other Operating Expenses plummeted 78.75% in 2021, then surged 30.05% in 2022.
  • Year by year, Other Operating Expenses stood at $286280.0 in 2021, then grew by 23.75% to $354261.0 in 2022, then decreased by 24.35% to $267996.0 in 2023, then plummeted by 34.5% to $175527.0 in 2024, then tumbled by 41.12% to $103343.0 in 2025.
  • Business Quant data shows Other Operating Expenses for CPHI at $103343.0 in Q3 2025, $103324.0 in Q2 2025, and $85788.0 in Q1 2025.